CATHAY BIOTECH INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 49.16 CNY | +12.99% |
|
+20.76% | -10.59% |
| 04-15 | Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6% | MT |
| 04-02 | Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on August 17, 2023. | CI |
| Sales 2023 | 2.11B 292M 23.27B | Sales 2024 * | - | Capitalization | 28.68B 3.96B 316B |
|---|---|---|---|---|---|
| Net income 2023 | 367M 50.68M 4.04B | Net income 2024 * | - | EV / Sales 2023 | 15.2 x |
| Net cash position 2023 * | - 0 0 | Net cash position 2024 * | - 0 0 | EV / Sales 2024 * | - |
| P/E ratio 2023 |
87.3
x | P/E ratio 2024 * |
-
| Employees | 2,324 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 33.14% |
More Fundamentals
* Assessed data
More news
| 1 day | +12.99% | ||
| 1 week | +20.76% | ||
| Current month | +11.37% | ||
| 1 month | +11.37% | ||
| 3 months | +5.18% | ||
| 6 months | -6.73% | ||
| Current year | -10.59% |
1 week
39.89
49.38
1 month
37.5049.38
Current year
37.5055.53
1 year
37.5067.00
3 years
37.50137.14
5 years
37.50141.43
10 years
37.50141.43
| Managers | Title | Age | Since |
|---|---|---|---|
Xiu Cai Liu
CHM | Chairman | 67 | 17/08/19 |
Wen Ying Yang
DFI | Director of Finance/CFO | - | - |
Chen Yang
COO | Chief Operating Officer | 40 | 30/04/19 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
William Keller
BRD | Director/Board Member | 75 | 17/08/19 |
Joachim Rudolf
BRD | Director/Board Member | 63 | 17/08/19 |
Xiu Cai Liu
CHM | Chairman | 67 | 17/08/19 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.69% | 1 M€ | -7.73% | - | |
| 0.81% | 45 M€ | -13.85% | - | |
| 0.81% | 45 M€ | -10.78% | - | |
| 0.81% | 39 M€ | -11.99% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/04/24 | 49.16 | +12.99% | 6,058,852 |
| 26/04/24 | 43.51 | +5.58% | 2,896,819 |
| 25/04/24 | 41.21 | +2.11% | 1,363,726 |
| 24/04/24 | 40.36 | -0.71% | 835,539 |
| 23/04/24 | 40.65 | -0.15% | 960,149 |
End-of-day quote Shanghai S.E., April 28, 2024
More quotes
Cathay Biotech Inc is a China-based company engaged in research, development, production and sales of biobased materials. The Company's primary products are biological long-chain dibasic acids and bio-based polyamide series, including lauric acid and brazilian acid, which are used in long-chain polyamides, fragrances, hot melt adhesives, lubricants, powder coatings and other areas. The Company sells its products to domestic and overseas markets.
Sector
Specialty Chemicals
Calendar
29/04/2024
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -10.59% | 3.5B | |
| +5.01% | 25.92B | |
| +11.55% | 1.7B | |
| -18.40% | 563M | |
| -21.41% | 384M | |
| -81.65% | 216M | |
| -11.15% | 114M |
- Stock Market
- Equities
- 688065 Stock
